Dumond, J B <br/><br/>
A phenotype-genotype approach to predicting CYP450 and P-glycoprotein drug interactions with the mixed inhibitor/inducer tipranavir/ritonavir.  [electronic resource] 

 -  Clinical pharmacology and therapeutics  Jun 2010 
 - 735-42 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1532-6535 
<br/><br/><label>Standard No.: </label>10.1038/clpt.2009.253  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ATP Binding Cassette Transporter, Subfamily B, Member 1--drug effects<br/>Adult<br/>Anti-HIV Agents--pharmacology<br/>Area Under Curve<br/>Cytochrome P-450 Enzyme System--drug effects<br/>Drug Combinations<br/>Drug Interactions<br/>Enzyme Induction--drug effects<br/>Enzyme Inhibitors--pharmacology<br/>Female<br/>Genotype<br/>HIV Protease Inhibitors--pharmacology<br/>Humans<br/>Intestinal Mucosa--metabolism<br/>Liver--metabolism<br/>Male<br/>Pharmaceutical Preparations--administration & dosage<br/>Phenotype<br/>Polymorphism, Single Nucleotide<br/>Pyridines--pharmacology<br/>Pyrones--pharmacology<br/>Ritonavir--pharmacology<br/>Sulfonamides<br/>Young Adult